ArticleFrontiers in oncology2026

Case Report: Durable response to mirvetuximab soravtansine in a patient with platinum-sensitive ovarian cancer and a diagnosis of myelodysplastic syndrome.

Theresa Steindl-Tomschizek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.